SEC Form D · filed May 21, 2018
AXIM BIOTECHNOLOGIES, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (16)
Philip Van Damme · Nijmegen, P7Exec · DirectorTimothy R. Scott · New York, NYDirectorJohn W. Huemoeller Ii · New York, NYDirectorRobert W. Malasek · New York, NYExecBlake N. Schroeder · New York, NYDirectorRobert R. Cunningham · New York, NYDirectorGeorge Anatassov · New York, NYExec · DirectorLekhram Changoer · Nijmegen, P7Exec · DirectorGeorge Anatassov · New York, NYExec · DirectorJohn W. Huemoeller Ii · New York, NYDirectorLekhram Changoer · Nijmegen, P7Exec · DirectorRobert W. Malasek · New York, NYExecBlake N. Schroeder · New York, NYDirectorRobert R. Cunningham · New York, NYDirectorPhilip Van Damme · Nijmegen, P7Exec · DirectorTimothy R. Scott · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗